Lyleq
- Product NDC
- 53002-1793
- 11-digit product format
- 530021793
- Labeler code
- 53002
- Product ID
- 53002-1793_d15c3fd7-8e69-4ac1-ad6d-172c8b5e7bde
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- NORETHINDRONE
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- RPK Pharmaceuticals, Inc.
- Application
- ANDA207304
- Marketing category
- ANDA
- Marketing start
- 2016-09-23
- Marketing end
- 0000-00-00
- Substance
- NORETHINDRONE
- Active strength
- 0 mg/1
- Pharmacologic classes
- Progesterone Congeners [CS], Progestin [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 53002-1793-1 | Lyleq | 1 in 1 PACKAGE | TABLET | 1 | | 3 |
| 53002-1793-1 | Lyleq | 28 in 1 BLISTER PACK | TABLET | 28 | | 3 |
| 53002-1793-3 | Lyleq | 28 in 1 BLISTER PACK | TABLET | 28 | | 3 |
| 53002-1793-3 | Lyleq | 3 in 1 CARTON | TABLET | 3 | | 3 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 53002-1793 | LYLEQ (NORETHINDRONE) TABLET [RPK PHARMACEUTICALS, INC.] | 3 | Legacy NDC, 4 package rows | 20220421_04569279-6b8e-49cf-86d3-f4921ffd9967.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 53002-1793-1 | 53002179301 | 1 BLISTER PACK in 1 PACKAGE (53002-1793-1) > 28 TABLET in 1 BLISTER PACK | 1 blister pack | 2021-12-31 | 0000-00-00 | No | No | Current |
| 53002-1793-3 | 53002179303 | 3 BLISTER PACK in 1 CARTON (53002-1793-3) > 28 TABLET in 1 BLISTER PACK | 3 blister pack | 2021-12-31 | 0000-00-00 | No | No | Current |